Neurogene (NGNE) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Neurogene (NGNE) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 73.00% |
| 10 | Neurogene | 771.78 Mn | 771.78 Mn | - | 87.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.49% |
| Dec 31, 2025 | -495,273.55% |
| Sep 30, 2025 | -639.96% |
| Jun 30, 2025 | -1,065.83% |
| Mar 31, 2025 | -6,248.97% |
| Dec 31, 2024 | 99.89% |
| Sep 30, 2024 | 99.97% |
| Jun 30, 2024 | 99.82% |
| Mar 31, 2024 | 99.99% |
| Dec 31, 2023 | -1,605,958.16% |
| Sep 30, 2023 | -2,472.10% |
| Jun 30, 2023 | -280.95% |
| Mar 31, 2023 | -691.80% |
| Dec 31, 2022 | 49.23% |
| Sep 30, 2022 | -17,492.53% |
| Jun 30, 2022 | -38,215.91% |
| Mar 31, 2022 | -149,348.84% |
| Dec 31, 2021 | 99.23% |
| Sep 30, 2021 | -1,474.90% |
| Jun 30, 2021 | -294.29% |